Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Stolfo

Showing results (31-40 of 201) with videos related to

Pageof 21
Sort By:
European Heart Journal. Cardiovascular Pharmacotherapy|May 19, 2023
Heart failure pharmacological treatments and outcomes in heart failure with mildly reduced ejection fractionDavide Stolfo, Lars H Lund, Gianfranco Sinagra, et al.
European Journal of Heart Failure|November 5, 2016
Insights into mildly dilated cardiomyopathy: temporal evolution and long-term prognosisMarta Gigli, Davide Stolfo, Marco Merlo, et al.
European Journal of Internal Medicine|June 6, 2021
Combining New Classes of Drugs for HFrEF: from Trials to Clinical PracticeGianfranco Sinagra, Linda Pagura, Davide Stolfo, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|April 16, 2019
ECG in dilated cardiomyopathy: specific findings and long-term prognostic significanceMarco Merlo, Denise Zaffalon, Davide Stolfo, et al.
Giornale Italiano Di Cardiologia (2006)|July 12, 2012
[Patent foramen ovale and cardiovascular stroke: the eternal dilemma]Davide Stolfo, Rita Piazza, Matteo Cassin, et al.
European Journal of Heart Failure|January 28, 2014
Long-term prognostic impact of therapeutic strategies in patients with idiopathic dilated cardiomyopathy: changing mortality over the last 30 yearsMarco Merlo, Alberto Pivetta, Bruno Pinamonti, et al.
European Journal of Heart Failure|July 30, 2024
Status and timing of angiotensin receptor-neprilysin inhibitor implementation in patients with heart failure and reduced ejection fraction: Data from the Swedish Heart Failure RegistryDavide Stolfo, Lina Benson, Felix Lindberg, et al.
JACC. Case Reports|August 22, 2025
Fulminant Myocarditis Presenting With Refractory Ventricular Fibrillation During BRAF/MEK Inhibitor TherapyAndrea Lalario, Filippo Maria Rubbo, Giulia Bassetto, et al.
European Journal of Heart Failure|December 5, 2015
Early right ventricular response to cardiac resynchronization therapy: impact on clinical outcomesDavide Stolfo, Elisabetta Tonet, Marco Merlo, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|August 18, 2018
Outcome of the multidimensional prognostic index in ultra-octogenarian patients hospitalized for cardiovascular diseasesCosimo Carriere, Davide Stolfo, Valeria Baglio, et al.
Pageof 21

Showing results (31-40 of 201) with videos related to

Sort By:
Pageof 21
European Heart Journal. Cardiovascular Pharmacotherapy|May 19, 2023
Heart failure pharmacological treatments and outcomes in heart failure with mildly reduced ejection fractionDavide Stolfo, Lars H Lund, Gianfranco Sinagra, et al.
European Journal of Heart Failure|November 5, 2016
Insights into mildly dilated cardiomyopathy: temporal evolution and long-term prognosisMarta Gigli, Davide Stolfo, Marco Merlo, et al.
European Journal of Internal Medicine|June 6, 2021
Combining New Classes of Drugs for HFrEF: from Trials to Clinical PracticeGianfranco Sinagra, Linda Pagura, Davide Stolfo, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|April 16, 2019
ECG in dilated cardiomyopathy: specific findings and long-term prognostic significanceMarco Merlo, Denise Zaffalon, Davide Stolfo, et al.
Giornale Italiano Di Cardiologia (2006)|July 12, 2012
[Patent foramen ovale and cardiovascular stroke: the eternal dilemma]Davide Stolfo, Rita Piazza, Matteo Cassin, et al.
European Journal of Heart Failure|January 28, 2014
Long-term prognostic impact of therapeutic strategies in patients with idiopathic dilated cardiomyopathy: changing mortality over the last 30 yearsMarco Merlo, Alberto Pivetta, Bruno Pinamonti, et al.
European Journal of Heart Failure|July 30, 2024
Status and timing of angiotensin receptor-neprilysin inhibitor implementation in patients with heart failure and reduced ejection fraction: Data from the Swedish Heart Failure RegistryDavide Stolfo, Lina Benson, Felix Lindberg, et al.
JACC. Case Reports|August 22, 2025
Fulminant Myocarditis Presenting With Refractory Ventricular Fibrillation During BRAF/MEK Inhibitor TherapyAndrea Lalario, Filippo Maria Rubbo, Giulia Bassetto, et al.
European Journal of Heart Failure|December 5, 2015
Early right ventricular response to cardiac resynchronization therapy: impact on clinical outcomesDavide Stolfo, Elisabetta Tonet, Marco Merlo, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|August 18, 2018
Outcome of the multidimensional prognostic index in ultra-octogenarian patients hospitalized for cardiovascular diseasesCosimo Carriere, Davide Stolfo, Valeria Baglio, et al.
Pageof 21